Percept PC Brainsense
Device Deep Brain Neurostimulation
PDI 00763000253363
General payments
$2,373,051
Research payments
$1,099,793
Through program year 2025, $2,373,051 in general payments and $1,099,793 in research payments were reported against Percept PC Brainsense (Deep Brain Neurostimulation).
No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.
By program year
8 rows| Year | Kind | Amount | Payments |
|---|---|---|---|
| 2025 | General | $679,496 | 5,056 |
| 2025 | Research | $238,340 | 85 |
| 2024 | General | $704,975 | 4,682 |
| 2024 | Research | $301,808 | 59 |
| 2023 | General | $463,382 | 3,158 |
| 2023 | Research | $292,962 | 61 |
| 2022 | General | $525,198 | 4,086 |
| 2022 | Research | $266,683 | 55 |
Breakdown
The top 5 of the 100 largest recipients; each share is of general payments naming this product in 2025.
The top 5 of 57 specialties; each share is of general payments naming this product to practitioners with a specialty in 2025. Each practitioner is counted under their primary specialty.
The top 5 of 48 states; each share is of general payments naming this product in 2025 where a state was reported.
Records
16,982 general · 260 researchEvery payment, record by record
Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.
What you are looking at
Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.